生物
髓系白血病
癌症研究
髓样
自然杀伤细胞
髓源性抑制细胞
CD33
白血病
自然杀伤性T细胞
NK-92
白细胞介素15
淋巴因子激活杀伤细胞
免疫学
细胞生物学
骨髓
CD16
造血
细胞毒性T细胞
白细胞介素12
细胞因子
NKG2D公司
T细胞
作者
Bethany L. Mundy-Bosse,McConnell Kathleen,Charlene Mao,Elshafa H. Ahmed,Li Chen,Steven D. Scoville,Aharon G. Freud,Jianhua Yu,Michael A. Caligiuri
出处
期刊:Blood
[Elsevier BV]
日期:2014-12-06
卷期号:124 (21): 754-754
被引量:3
标识
DOI:10.1182/blood.v124.21.754.754
摘要
Acute myeloid leukemia (AML) is a devastating disease primarily affecting adults. Immune evasion is a major mechanism of AML persistence, and represents a barrier for long-term clinical success. Natural killer (NK) cells are a key component of the innate immune system and hold promise as a tool for effective anti-leukemia therapy. However, to date, the clinical success of NK therapy has been disappointing, indicating additional immune evasion strategies may affect the ability of NK cells to function in patients. We hypothesized that AML may evade the innate immune system by inhibiting NK cell maturation. To evaluate NK function and maturation during AML progression, our lab utilized a novel knock-in model of AML that expresses both Flt3-ITD and Mll-PTD mutations (PTD/ITD), and develops AML with 100% penetrance and recapitulates human disease. For these studies, both primary PTD/ITD mice and transplanted AML blasts were used. For transplant studies, AML or wild-type (WT) control cells (CD45.2+) were transplanted into irradiated C57BL/6 (CD45.1+) naive recipients. Normal (CD45.1+) NK cells were defined as NK1.1+/CD3- by flow cytometry, and expression of receptors was determined within this population. NK cells in leukemic mice exhibited a reduction in the activating receptors Ly49D and Ly49H in the spleen, blood, LN, and bone marrow. There was also an increase in the inhibitory receptor Ly49C/I and NKG2C/A/E (both p NK maturation was then evaluated by examining CD11b and CD27 protein expression on NK1.1+/CD3- cells in the spleen, bone marrow, blood, and LN. CD11b+/CD27+ (DP) NK cells were reduced in the spleen as well as bone marrow, blood and LN (p Disclosures No relevant conflicts of interest to declare.
科研通智能强力驱动
Strongly Powered by AbleSci AI